Hepatic stellate cell activation in nonalcoholic steatohepatitis and fatty liver

被引:98
|
作者
Washington, K
Wright, K
Shyr, Y
Hunter, EB
Olson, S
Raiford, DS
机构
[1] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Med Ctr, Dept Surg, Nashville, TN 37232 USA
[3] Vanderbilt Univ, Med Ctr, Dept Prevent Med, Nashville, TN 37232 USA
[4] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN 37232 USA
[5] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37232 USA
关键词
nonalcoholic steatohepatitis; fibrosis; steatosis; hepatic stellate cell;
D O I
10.1053/hupa.2000.8440
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Factors associated with the development of fibrosis in nonalcoholic steatohepatitis (NASH) are largely unknown, although an association with increased hepatic iron has been suggested. Hepatic stellate cells are the principal collagen-producing cells in many liver diseases and when activated express alpha-smooth muscle actin (alpha-SMA). Hepatic stellate cell activation and association with fibrosis, necroinflammatory activity steatosis, and stainable iron in 60 cases of NASH and 16 cases of steatosis were evaluated. All 76 patients were obese or had other risk factors for NASH. All biopsy specimens were stained for alpha-smooth muscle actin to evaluate the pattern of hepatic stellate cell activation and were evaluated for inflammatory activity (0 to 3), fibrosis (0 to 4), and stainable iron stores (0 to 4). The zonal location of activated stellate cells was recorded, and the degree of activation was graded as high-grade or low-grade based on the percentage of lobular alpha-SMA+ cells. Activated stellate cells were identified in the hepatic lobule in 74 of 76 biopsy specimens and graded as low-grade in 26 and high-grade in 48. Zone 3 was involved in 72 of 74 positive cases, and in 33 cases, the activated stellate cells were preferentially located in zone 3, The degree of stellate cell activation correlated with fibrosis but not with inflammatory activity, severity of steatosis, or stainable iron. In most cases, the degree of stellate cell activation paralleled the degree of hepatic fibrosis, but in 25 cases, the degree of hepatic stellate cell activation was greater than expected, raising the question of whether such patients are at risk for disease progression. Copyright (C) 2000 by W.B. Saunders Company.
引用
收藏
页码:822 / 828
页数:7
相关论文
共 50 条
  • [31] Hepatic stellate cell activation in non-alcoholic steatohepatitis.
    Washington, K
    Wright, K
    Hunter, E
    Raiford, DS
    LABORATORY INVESTIGATION, 1999, 79 (01) : 169A - 169A
  • [32] Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Implications for liver transplantation
    Younossi, Zobair M.
    LIVER TRANSPLANTATION, 2018, 24 (02) : 166 - 170
  • [33] Frequency of nonalcoholic fatty liver disease, nonalcoholic steatohepatitis and degree of hepatic steatosis in African American patients
    Giday, SA
    Ashiny, Z
    Naab, T
    Banks, AT
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S133 - S133
  • [34] Probiotics in Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, and Cirrhosis
    Qamar, Amir A.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2015, 49 : S28 - S32
  • [35] Histopathological findings of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
    Masayoshi Kage
    Shinichi Aishima
    Hironori Kusano
    Hirohisa Yano
    Journal of Medical Ultrasonics, 2020, 47 : 549 - 554
  • [36] Overview of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis Management
    Kim, Soo Ki
    Kim, Ke Ih
    Kim, Soo Ryang
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2019, 139 (09): : 1147 - 1153
  • [37] Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
    Yoshihisa Takahashi
    Yurie Soejima
    Toshio Fukusato
    World Journal of Gastroenterology, 2012, (19) : 2300 - 2308
  • [38] Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma
    Massoud, Omar
    Charlton, Michael
    CLINICS IN LIVER DISEASE, 2018, 22 (01) : 201 - +
  • [39] Current Treatment of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
    Hung, Chun Kit
    Bodenheimer, Henry C., Jr.
    CLINICS IN LIVER DISEASE, 2018, 22 (01) : 175 - +
  • [40] Histopathological findings of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
    Kage, Masayoshi
    Aishima, Shinichi
    Kusano, Hironori
    Yano, Hirohisa
    JOURNAL OF MEDICAL ULTRASONICS, 2020, 47 (04) : 549 - 554